Replaces Prod. #: ALX-480-012
Rp-cAMPS is a potent and specific competitive inhibitor of the activation of cAMP-dependent protein kinases by cAMP (IC50=4.9 µM) . Its cell permeability and complete resistance to cyclic nucleotide phosphodiesterases make it a unique tool for studying cAMP-dependent signaling. Significantly more lipophilc as compared to cAMP and thus membrane permeable in many biological systems. This product is not sterile.
Product Details
| Formula: | C10H11N5O5PS . C6H16N |
| |
| MW: | 446.5 |
| |
| Source: | Synthetic. |
| |
| CAS: | 151837-09-1 |
| |
| Purity: | ≥98% (HPLC) |
| |
| Appearance: | Clear film. |
| |
| Solubility: | Soluble in water (25mg/ml), aqueous buffers, methanol, 100% ethanol or DMSO. |
| |
| Shipping: | Ambient Temperature |
| |
| Long Term Storage: | -20°C |
| |
| Use/Stability: | Store, as supplied, at -20°C for up to 1 year. Store solutions at -20°C for up to 3 months. |
| |
| Regulatory Status: | RUO - Research Use Only |
| |
Please mouse over
Product Literature References
Disruption of Mitochondrial-associated ER membranes by HIV-1 tat protein contributes to premature brain aging: S.P. Arjona, et al.; CNS Neurosci. Ther.
29, 365 (2023),
Abstract;
Biased signaling initiated by agouti-related peptide through human melanocortin-3 and − 4 receptors: Z. Yang & Y.X. Tao; Biochim. Biophys. Acta
1862, 1485 (2016),
Application(s): Cell culture,
Abstract;
Stimulation of the ERK pathway by GTP-loaded Rap1 requires the concomitant activation of Ras, protein kinase C, and protein kinase A in neuronal cells: T. Bouschet et al.; J. Biol. Chem.
278, 4778 (2003),
Abstract;
Cell-permeable non-hydrolyzable cAMP derivatives as tools for analysis of signaling pathways controlling gene regulation in Dictyostelium: P. Schaap et al.; J. Biol. Chem.
268, 6323 (1993),
Abstract;
Regulation of kainate receptors by cAMP-dependent protein kinase and phosphatases: L.Y. Wang et al.; Science
253, 1132 (1991),
Abstract;
Inhibition of cGMP-dependent protein kinase by (Rp)-guanosine 3’,5’-monophosphorothioates: E. Butt et al.; FEBS Lett.
263, 47 (1990),
Abstract;
Probing the cyclic nucleotide binding sites of cAMP-dependent protein kinases I and II with analogs of adenosine 3’,5’-cyclic phosphorothioates: W.R.G. Dostmann et al.; J. Biol. Chem.
265, 10484 (1990),
Abstract;
A mechanistic and kinetic analysis of the interactions of the diastereoisomers of adenosine 3’,5’-(cyclic)phosphorothioate with purified cyclic AMP-dependent protein kinase: J.D. Rothermel & L.J. Parker Bothelo; Biochem. J.
251, 757 (1988),
Abstract;
cAMP analog antagonists of cAMP action: L.H. Botelho et al.; Methods Enzymol.
159, 159 (1988),
Abstract;
Hydrolysis of cyclic nucleotides by a purified cGMP-stimulated phosphodiesterase: structural requirements for hydrolysis: T. Braumann et al.; Biochim. Biophys. Acta.
871, 199 (1986),
Abstract;
